We are analyzing https://link.springer.com/article/10.1007/s00125-007-0791-0.

Title:
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia | Diabetologia
Description:
Aims/hypothesis Recent evidence suggests that a particular gut microbial community may favour occurrence of the metabolic diseases. Recently, we reported that high-fat (HF) feeding was associated with higher endotoxaemia and lower Bifidobacterium species (spp.) caecal content in mice. We therefore tested whether restoration of the quantity of caecal Bifidobacterium spp. could modulate metabolic endotoxaemia, the inflammatory tone and the development of diabetes. Methods Since bifidobacteria have been reported to reduce intestinal endotoxin levels and improve mucosal barrier function, we specifically increased the gut bifidobacterial content of HF-diet-fed mice through the use of a prebiotic (oligofructose [OFS]). Results Compared with normal chow-fed control mice, HF feeding significantly reduced intestinal Gram-negative and Gram-positive bacteria including levels of bifidobacteria, a dominant member of the intestinal microbiota, which is seen as physiologically positive. As expected, HF-OFS-fed mice had totally restored quantities of bifidobacteria. HF-feeding significantly increased endotoxaemia, which was normalised to control levels in HF-OFS-treated mice. Multiple-correlation analyses showed that endotoxaemia significantly and negatively correlated with Bifidobacterium spp., but no relationship was seen between endotoxaemia and any other bacterial group. Finally, in HF-OFS-treated-mice, Bifidobacterium spp. significantly and positively correlated with improved glucose tolerance, glucose-induced insulin secretion and normalised inflammatory tone (decreased endotoxaemia, plasma and adipose tissue proinflammatory cytokines). Conclusions/interpretation Together, these findings suggest that the gut microbiota contribute towards the pathophysiological regulation of endotoxaemia and set the tone of inflammation for occurrence of diabetes and/or obesity. Thus, it would be useful to develop specific strategies for modifying gut microbiota in favour of bifidobacteria to prevent the deleterious effect of HF-diet-induced metabolic diseases.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Pets
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

mice, pubmed, article, gut, google, scholar, cas, diet, endotoxaemia, glucose, insulin, plasma, bifidobacteria, spp, bacteria, microbiota, fig, metabolic, dietary, hfofs, bifidobacterium, intestinal, fed, control, weight, hfcell, content, prebiotic, data, adipose, diabetes, inflammatory, bacterial, inflammation, obesity, fibre, cani, highfat, levels, increased, compared, significantly, correlated, body, prebiotics, nutr, group, tolerance, increase, fat,

Topics {✒️}

tumor necrosis factor-alpha hf-cell high-fat diet bio-breeding diabetes-prone rat hf-ofs high-fat diet hf-ofs-fed mice exhibit hf-cell mice showed hf-diet-induced metabolic disorders short-chain fatty acids hf-diet-induced metabolic diseases multiple-correlation analyses showed proglucagon mrna precursor hf high-fat diet high-fat hf-cell glucose-induced insulin secretion trans-epithelial electrical resistance ob/ob mice treated gram-negative bacteria present obesity-induced insulin resistance hf-diet-induced inflammation hf-diet-treated mice cytophaga–flavobacter–bacteroides phylum phylum cytophaga–flavobacter–bacteroides gram-negative bacteroides mib hf-diet-induced obesity [9] hf diet-induced obesity hf-ofs-treated mice hf-ofs-treated-mice microcrystalline cellulose [hf-cell] hf-ofs mice impacted gut-derived bacterial translocation hf-diet-fed mice hf-cell-fed mice low-grade inflammatory tone hf-ofs-fed mice hf-ofs fed mice body weight gain hf-cell mice compared hf-fed mice compared hotamisligil gs gram-negative bacteria gut microbial community microbial ecology obesity-linked insulin resistance high-fat diet gram-positive bacteria murine intestinal microflora colonic proglucagon mrna major gram-positive high-fat feeding endotoxaemia article published

Questions {❓}

Is the gut flora involved in the development of type 1 diabetes?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
         description:Recent evidence suggests that a particular gut microbial community may favour occurrence of the metabolic diseases. Recently, we reported that high-fat (HF) feeding was associated with higher endotoxaemia and lower Bifidobacterium species (spp.) caecal content in mice. We therefore tested whether restoration of the quantity of caecal Bifidobacterium spp. could modulate metabolic endotoxaemia, the inflammatory tone and the development of diabetes. Since bifidobacteria have been reported to reduce intestinal endotoxin levels and improve mucosal barrier function, we specifically increased the gut bifidobacterial content of HF-diet-fed mice through the use of a prebiotic (oligofructose [OFS]). Compared with normal chow-fed control mice, HF feeding significantly reduced intestinal Gram-negative and Gram-positive bacteria including levels of bifidobacteria, a dominant member of the intestinal microbiota, which is seen as physiologically positive. As expected, HF-OFS-fed mice had totally restored quantities of bifidobacteria. HF-feeding significantly increased endotoxaemia, which was normalised to control levels in HF-OFS-treated mice. Multiple-correlation analyses showed that endotoxaemia significantly and negatively correlated with Bifidobacterium spp., but no relationship was seen between endotoxaemia and any other bacterial group. Finally, in HF-OFS-treated-mice, Bifidobacterium spp. significantly and positively correlated with improved glucose tolerance, glucose-induced insulin secretion and normalised inflammatory tone (decreased endotoxaemia, plasma and adipose tissue proinflammatory cytokines). Together, these findings suggest that the gut microbiota contribute towards the pathophysiological regulation of endotoxaemia and set the tone of inflammation for occurrence of diabetes and/or obesity. Thus, it would be useful to develop specific strategies for modifying gut microbiota in favour of bifidobacteria to prevent the deleterious effect of HF-diet-induced metabolic diseases.
         datePublished:2007-09-06T00:00:00Z
         dateModified:2007-09-06T00:00:00Z
         pageStart:2374
         pageEnd:2383
         sameAs:https://doi.org/10.1007/s00125-007-0791-0
         keywords:
            Bifidobacteria
            Diabetes
            Endotoxin
            GLP-1
            Glucagon-like peptide-1
            Gut microflora
            Inflammation
            Obesity
            Prebiotics
            Internal Medicine
            Metabolic Diseases
            Human Physiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig7_HTML.gif
         isPartOf:
            name:Diabetologia
            issn:
               1432-0428
               0012-186X
            volumeNumber:50
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:P. D. Cani
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:A. M. Neyrinck
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:F. Fava
               affiliation:
                     name:The University of Reading
                     address:
                        name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Knauf
               affiliation:
                     name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
                     address:
                        name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. G. Burcelin
               affiliation:
                     name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
                     address:
                        name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K. M. Tuohy
               affiliation:
                     name:The University of Reading
                     address:
                        name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. R. Gibson
               affiliation:
                     name:The University of Reading
                     address:
                        name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. M. Delzenne
               affiliation:
                     name:Université catholique de Louvain
                     address:
                        name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
      description:Recent evidence suggests that a particular gut microbial community may favour occurrence of the metabolic diseases. Recently, we reported that high-fat (HF) feeding was associated with higher endotoxaemia and lower Bifidobacterium species (spp.) caecal content in mice. We therefore tested whether restoration of the quantity of caecal Bifidobacterium spp. could modulate metabolic endotoxaemia, the inflammatory tone and the development of diabetes. Since bifidobacteria have been reported to reduce intestinal endotoxin levels and improve mucosal barrier function, we specifically increased the gut bifidobacterial content of HF-diet-fed mice through the use of a prebiotic (oligofructose [OFS]). Compared with normal chow-fed control mice, HF feeding significantly reduced intestinal Gram-negative and Gram-positive bacteria including levels of bifidobacteria, a dominant member of the intestinal microbiota, which is seen as physiologically positive. As expected, HF-OFS-fed mice had totally restored quantities of bifidobacteria. HF-feeding significantly increased endotoxaemia, which was normalised to control levels in HF-OFS-treated mice. Multiple-correlation analyses showed that endotoxaemia significantly and negatively correlated with Bifidobacterium spp., but no relationship was seen between endotoxaemia and any other bacterial group. Finally, in HF-OFS-treated-mice, Bifidobacterium spp. significantly and positively correlated with improved glucose tolerance, glucose-induced insulin secretion and normalised inflammatory tone (decreased endotoxaemia, plasma and adipose tissue proinflammatory cytokines). Together, these findings suggest that the gut microbiota contribute towards the pathophysiological regulation of endotoxaemia and set the tone of inflammation for occurrence of diabetes and/or obesity. Thus, it would be useful to develop specific strategies for modifying gut microbiota in favour of bifidobacteria to prevent the deleterious effect of HF-diet-induced metabolic diseases.
      datePublished:2007-09-06T00:00:00Z
      dateModified:2007-09-06T00:00:00Z
      pageStart:2374
      pageEnd:2383
      sameAs:https://doi.org/10.1007/s00125-007-0791-0
      keywords:
         Bifidobacteria
         Diabetes
         Endotoxin
         GLP-1
         Glucagon-like peptide-1
         Gut microflora
         Inflammation
         Obesity
         Prebiotics
         Internal Medicine
         Metabolic Diseases
         Human Physiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-007-0791-0/MediaObjects/125_2007_791_Fig7_HTML.gif
      isPartOf:
         name:Diabetologia
         issn:
            1432-0428
            0012-186X
         volumeNumber:50
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:P. D. Cani
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:A. M. Neyrinck
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:F. Fava
            affiliation:
                  name:The University of Reading
                  address:
                     name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Knauf
            affiliation:
                  name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
                  address:
                     name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. G. Burcelin
            affiliation:
                  name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
                  address:
                     name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K. M. Tuohy
            affiliation:
                  name:The University of Reading
                  address:
                     name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. R. Gibson
            affiliation:
                  name:The University of Reading
                  address:
                     name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. M. Delzenne
            affiliation:
                  name:Université catholique de Louvain
                  address:
                     name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Diabetologia
      issn:
         1432-0428
         0012-186X
      volumeNumber:50
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Université catholique de Louvain
      address:
         name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
      name:The University of Reading
      address:
         name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
         type:PostalAddress
      name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
      address:
         name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
         type:PostalAddress
      name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
      address:
         name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
         type:PostalAddress
      name:The University of Reading
      address:
         name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
         type:PostalAddress
      name:The University of Reading
      address:
         name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
         type:PostalAddress
      name:Université catholique de Louvain
      address:
         name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:P. D. Cani
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:A. M. Neyrinck
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:F. Fava
      affiliation:
            name:The University of Reading
            address:
               name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
               type:PostalAddress
            type:Organization
      name:C. Knauf
      affiliation:
            name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
            address:
               name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
               type:PostalAddress
            type:Organization
      name:R. G. Burcelin
      affiliation:
            name:Rangueil Institute of Molecular Medicine, I2MR, IFR31
            address:
               name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
               type:PostalAddress
            type:Organization
      name:K. M. Tuohy
      affiliation:
            name:The University of Reading
            address:
               name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
               type:PostalAddress
            type:Organization
      name:G. R. Gibson
      affiliation:
            name:The University of Reading
            address:
               name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
               type:PostalAddress
            type:Organization
      name:N. M. Delzenne
      affiliation:
            name:Université catholique de Louvain
            address:
               name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
      name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium
      name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
      name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
      name:Rangueil Institute of Molecular Medicine, I2MR, IFR31, Toulouse, France
      name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
      name:Food Microbial Sciences Unit, Department of Food Biosciences, The University of Reading, Reading, UK
      name:Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium

External Links {🔗}(181)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.7s.

LINK . SPRINGER . COM {}